WHY MEDTRONIC BET ON SCIENTIA VASCULAR FOR $550 MILLION: Medtronic's acquisition of Scientia Vascular signals global confidence in Utah's fastgrowing medical device hub -- and sets the stage for expansion, jobs and lifesaving innovation.

Saved in:

Bibliographic Details
Title:	WHY MEDTRONIC BET ON SCIENTIA VASCULAR FOR $550 MILLION: Medtronic's acquisition of Scientia Vascular signals global confidence in Utah's fastgrowing medical device hub -- and sets the stage for expansion, jobs and lifesaving innovation.
Authors:	Zuccarello, Michael
Source:	Utah Business. May2026, Vol. 41 Issue 5, p32-34. 3p.
Subjects:	Vascular catheters, Mergers & acquisitions, Minimally invasive procedures, Medical equipment industry, Medical equipment, Medtronic PLC, Neurovascular surgery, Medical innovations
Geographic Terms:	Salt Lake City (Utah), Utah
Abstract:	The article focuses on Medtronic’s $550 million acquisition of Scientia Vascular, a Utah-based neurovascular medical device company specializing in guidewires and catheters that treat strokes and brain aneurysms. Scientia’s products, including the Aristotle guidewire and Plato microcatheter, enable minimally invasive procedures that improve patient outcomes by reducing treatment time and avoiding open surgery. The acquisition reflects Medtronic’s strategic intent to expand Scientia’s international reach, leveraging Utah’s growing life sciences industry and skilled workforce. Founded in 2007 and relocated to Salt Lake City in 2013, Scientia has rapidly grown its revenue and maintains a family-oriented culture, with key leadership roles held by the founding family. [Extracted from the article]
	Copyright of Utah Business is the property of Utah Business Magazine and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	Regional Business News

Description
Abstract:	The article focuses on Medtronic’s $550 million acquisition of Scientia Vascular, a Utah-based neurovascular medical device company specializing in guidewires and catheters that treat strokes and brain aneurysms. Scientia’s products, including the Aristotle guidewire and Plato microcatheter, enable minimally invasive procedures that improve patient outcomes by reducing treatment time and avoiding open surgery. The acquisition reflects Medtronic’s strategic intent to expand Scientia’s international reach, leveraging Utah’s growing life sciences industry and skilled workforce. Founded in 2007 and relocated to Salt Lake City in 2013, Scientia has rapidly grown its revenue and maintains a family-oriented culture, with key leadership roles held by the founding family. [Extracted from the article]
ISSN:	10911707